All News

How Can Cancer Survivors Help The Newly Diagnosed?

May 8th 2021, 6:00pm


Cancer survivors have the responsibility of sharing their knowledge of living in the world of cancer with the newly diagnosed, writes one survivor. Here, she shares ways to offer help.

CURE Honors World Ovarian Cancer Day

May 8th 2021, 3:00pm


Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.

Derazantinib May Demonstrate Promising Disease Control in Some Patients With Cholangiocarcinoma

May 7th 2021, 9:00pm


Interim results from a phase 2 study demonstrated that patients inoperable or advanced intrahepatic cholangiocarcoma and a FGFR2 gene mutation had a disease control rate of 79% when treated with derazantinib.

You May Have Second Thoughts When Receiving a Cancer Diagnosis

May 7th 2021, 6:00pm


Luckily, obtaining a second opinion has become easier with advances in telehealth and other virtual technologies, which allow patients to share their medical records and test results with physicians and pathologists to potentially improve treatment plans.

Rage at the Sun

May 7th 2021, 4:00pm


A melanoma survivor pens a poem about his cancer journey, losing his wife to melanoma and how he lives his life after these experiences.

Friday Frontline: A Two-Time Cancer Survivor Becomes the Oldest Living American, A Nurse Serves as a Surrogate for a Cancer Survivor, And More

May 7th 2021, 3:00pm


From a 114-year-old cancer survivor breaking records to an operating room nurse giving birth to a cancer survivor’s baby, here’s what’s happening in the cancer landscape this week.

Prolonging Recurrence-Free Survival With Keytruda Does Not Come at the Price of Reduced Quality of Life for Patients with Melanoma

May 7th 2021, 1:00pm


Patients with melanoma treated with Keytruda had improved recurrence-free survival without an effect on their quality of life.

Venclexta With a Hypomethylating Agent Shows Promise for Patients with Acute Myeloid Leukemia

May 6th 2021, 9:00pm


Compared to a hypomethylating agent alone, combining the agent with Venclexta improved complete remission rates in patients with blast-phase myeloproliferative neoplasm.

FDA Committee Recommends Continuing Accelerated Approval Status of Tecentriq in Certain Patients with Metastatic Triple-Negative Breast Cancer

May 6th 2021, 6:00pm


Members of an FDA committee voted in favor of Tecentriq plus Abraxane keeping its accelerated approval for the treatment of adults with unresectable, locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1.

When Oncologists Retire, Their Patients Must Learn to Embrace Change

May 6th 2021, 4:00pm


“We’re all blessed that there are so many dedicated, caring health care professionals willing to step in and fill the void when members of the team move or retire,” writes a patient with cancer. “We can never forget how tough a gig it is or say thank you enough.”